Citations

Showing 10 of 108119 citations.

Primary results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) versus tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy.
Margolese, Richard G., Julian, Thomas B. , Costantino, Joseph P., Vallow, Laura A., Albain, Kathy S. , Whitworth, Pat W. , Cianfrocca, Mary, Gross, Howard M., Soori, Gamini S. , Hopkins, Judith O. , Sturtz, Keren , Wozniak, Timothy F., Seay, Thomas E., Mamounas, Eleftherios P. , Cecchini, Reena S. , Ganz, Patricia A. , Brufsky, Adam , Fehrenbacher, Louis , Mamounas, Eleftherios P. , Wolmark, Norman

Mayo Clinic

Journal of Clinical Oncology | March 8, 2019 | Volume: 33 | Issue: 15_suppl | Pages: LBA500-LBA500

10.1200/jco.2015.33.15_suppl.lba500 Get It

Three-Dimensional Printed Biopatches With Conductive Ink Facilitate Cardiac Conduction When Applied to Disrupted Myocardium
Pedrotty, Dawn , Kuzmenko, Volodymyr , Sugrue, Alan , Livia, Christopher , Vaidya, Vaibhav R. , Asirvatham, Samuel J. , Gatenholm, Paul , Pedrotty, Dawn M, Sugrue, Alan M, Asirvatham, Samuel J , Livia, Christopher , Karabulut, Erdem , McLeod, Christopher J. , Kapa, Suraj

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | March 8, 2019 | Volume: 12 | Issue: 3 | Pages: No page available

10.1161/circep.118.006920 | PMID 30845835 Get It

Background: Reentrant ventricular arrhythmias are a major cause of sudden death in patients with structural heart disease. Current treatments focus on electrically homogenizing regions of scar contributing to ventricular arrhythmia with ablation or altering conductive properties using antiarrhythmic drugs. The high conductivity of carbon nanotubes may allow restoration of conduction in regions where impaired electrical conduction results in functional abnormalities. We propose a new concept for arrhythmia treatment using a stretchable, flexible biopatch with conductive properties to attempt to restore conduction across regions in which activation is disrupted. Methods: Carbon nanotube patches composed of nanofibrillated cellulose/single-walled carbon nanotube ink 3-dimensionally printed in conductive patterns onto bacterial nanocellulose were developed and evaluated for conductivity, flexibility, and mechanical properties. The patches were applied on 6 canines to epicardium before and after surgical disruption. Electroanatomic mapping was performed on normal epicardium, then repeated over surgically disrupted epicardium, and then finally with the patch applied passively. Results: We developed a 3-dimensional printable carbon nanotube ink complexed on bacterial nanocellulose that was (1) expressable through 3-dimensional printer nozzles, (2) electrically conductive, (3) flexible, and (4) stretchable. Six canines underwent thoracotomy, and, during epicardial ventricular pacing, mapping was performed. We demonstrated disruption of conduction after surgical incision in all 6 canines based on activation mapping. The patch resulted in restored conduction based on mapping and assessment of conduction direction and velocities in all canines. Conclusions: We have demonstrated 3-dimensional custom-printed electrically conductive carbon nanotube patches can be surgically manipulated to improve cardiac conduction when passively applied to surgically disrupted epicardial myocardium in canines.
Chemotherapy‐induced skin toxicity and capillary leak syndrome
Hunjan, Manrup , Nowsheen, Somaira , Ramos‐Rodriguez, Alvaro J. , Bridges, Alina G. , Lehman, Julia S. , Hashmi, Shahrukh K. , El-Azhary, Rokea A, Lehman, Julia S , el‐Azhary, Rokea A.

Mayo Clinic

International Journal of Dermatology | March 8, 2019 | Volume: 58 | Issue: 7 | Pages: 856-860

10.1111/ijd.14392 | PMID 30847892 Get It

AbstractBackgroundThe occurrence of chemotherapy‐related adverse cutaneous reactions in the setting of capillary leak syndrome (CLS) is quite rare. Our objective was to identify the type of skin reactions associated with CLS.MethodsLeukemia or hematopoietic stem cell transplant patients between January 2010 and December 2017 were identified, and medical records were reviewed for a dermatology consultation occurring concomitantly with CLS.ResultsFive patients were identified, two with a diagnosis of toxic erythema of chemotherapy (TEC) and three others with a skin diagnosis of toxic epidermal necrolysis (TEN). Pathology of all patients was available for clinical‐pathologic confirmation.ConclusionsAlthough TEC is generally self‐limited, both TEC and TEN can present with severe adverse skin manifestations during CLS secondary to toxicity from chemotherapy.
Comments on pre‐fibrotic myelofibrosis and how should it be managed
Barbui, Tiziano , Thiele, Jüergen, Gisslinger, Heinz , Orazi, Attilio , Gianelli, Umberto , Beham‐Schmid, Christine, Tefferi, Ayalew , Tefferi, Ayalew , Gianelli, Umberto , Orazi, Attilio , Vannucchi, Alessandro M.

Mayo Clinic

British Journal of Haematology | March 8, 2019 | Volume: 186 | Issue: 2 | Pages: 358-360

10.1111/bjh.15840 | PMID 30847907 Get It

Postoperative Euglycemic Diabetic Ketoacidosis and Encephalopathy Related to SGLT-2 Inhibitors: A Case Report and Discussion of Diabetes Treatment and “Sweet Pee Encephalopathy” in Perioperative Hospital Management
Mackintosh, Christopher, Tewari, Arti , Siegel, Jason , Wang, R Doris, Freeman, William T. , Freeman, William, Freeman, William

Mayo Clinic

The Neurohospitalist | March 7, 2019 | Volume: 10 | Issue: 1 | Pages: 51-54

10.1177/1941874419835035 | PMID 31839866 Get It

During preanesthesia evaluation, patient medications are reviewed and many are not administered on the day of surgery. Additionally, neurosurgical patients can develop postoperative encephalopathy from a variety of etiologies, including metabolic derangements. We report a case of postoperative neurosurgical euglycemic ketoacidosis which presented as unexplained encephalopathy and was the result of continued action of the patient’s serum glucose cotransporter-2 (SGLT-2) inhibitor combined with perioperative fasting. A 68-year-old woman with a history of type 2 diabetes mellitus was admitted to the neurocritical care service after resection of a left temporal meningioma. On postop day 1, she became lethargic and with worsening aphasia. Laboratory studies revealed blood glucose 140 to 160 mmol/L, bicarbonate 9 mmol/L, anion gap of 21, and pH of 7.2. Urine was positive for ketones and glucose, and serum was positive for β-hydroxybutyrate. Endocrinology was consulted and the patient was diagnosed with euglycemic diabetic ketoacidosis and treated with insulin until her anion gap closed. Over the next 2 days, her neurological examination improved to baseline. Although the patient did not take empagliflozin the day of surgery, the drug has a half-life of >12 hours, and other reports have described continued glycosuria for up to 10 days after drug discontinuation. This case illustrates the need for increased awareness of SGLT-2 inhibitors and “sweet pee encephalopathy” among neurosurgical and neurointensivist teams as well as potential modification of perioperative management of patients using newly emerging SGLT-2 inhibiting pharmaceuticals.
Implementing a Palliative Medicine Music Therapy Program: A Quality Improvement Project
Wood, Christina M., Cutshall, Susanne M. , Wiste, Rachel M., Gentes, Rachel C., Rian, Johanna S., Tipton, Amie M., Ann-Marie, Dose, Mahapatra, Saswati , Carey, Elise C. , Strand, Jacob J. , Wood, Christina

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | March 7, 2019 | Volume: 36 | Issue: 7 | Pages: 603-607

10.1177/1049909119834878 | PMID 30845807 Get It

Objectives: Recent evidence suggests that music therapy, a holistic method of care, potentially is beneficial for symptom management. This quality improvement project aimed to evaluate the effect of music therapy on symptom management and coping skills of patients receiving palliative care and to measure patient satisfaction with the therapy. A secondary aim was to evaluate staff perception of patient outcomes of music therapy services. Methods: Palliative care clinicians attended a 30-minute education session on music therapy before the project was initiated. Study participants were patients and their families who were cared for by the inpatient palliative care consulting service at Mayo Clinic (Rochester, Minnesota) from June 1 through December 31, 2016. Patients were eligible if they required ongoing management of pain and anxiety or needed adaptive coping strategies. Patients and families were asked to complete a survey after each music therapy session. Staff were asked to complete a survey after completion of the project. Results: Music therapy was provided to 57 patients and 53 family members. Patient surveys indicated a decrease in anxiety and pain. All patients reported that music therapy facilitated stress relief, relaxation, pain relief, spiritual support, emotional support, and a general feeling of wellness. All participants recommended music therapy services for others. Palliative care clinicians reported that music therapy added value as a holistic service. Conclusions: In this quality improvement project, music therapy positively affected multiple domains of well-being for patients receiving palliative care.
The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease
Whitwell, Jennifer L. , Martin, Peter R. , Graff‐Radford, Jonathan, Senjem, Matthew L. , Weigand, Stephen D. , Spychalla, Anthony J., Drubach, Daniel A., Jack, Clifford R. , Lowe, Val J. , Josephs, Keith A. , Jack, Clifford R , Senjem, Matthew L , Graff‐Radford, Jonathan , Machulda, Mary M. , Schwarz, Christopher G.

Mayo Clinic

Alzheimer's & Dementia | March 7, 2019 | Volume: 15 | Issue: 5 | Pages: 675-685

10.1016/j.jalz.2018.12.016 | PMID 30853465 Get It

AbstractIntroductionLittle is known about the role of age on neurodegeneration and protein deposition in atypical variants of Alzheimer's disease (AD).MethodsRegional tau and β‐amyloid positron emission tomography standard uptake value ratios and gray matter volumes were calculated in a cohort of 42 participants with atypical AD. The relationship between regional metrics and age was modeled using a Bayesian hierarchical linear model.ResultsAge was strongly associated with tau uptake across all cortical regions, particularly parietal, with greater uptake in younger participants. Younger age was associated with smaller parietal and lateral temporal volumes. Regional β‐amyloid differed little by age. Age showed a stronger association with tau than volume and β‐amyloid in all cortical regions. Age was not associated with cognitive performance.DiscussionAge is an important determinant of severity of cortical tau uptake in atypical AD, with young participants more likely to show widespread and severe cortical tau uptake.
Ibrutinib combined with bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): First results from a randomized, double-blind, placebo-controlled, phase III study.
Chanan‐Khan, Asher , Fraser, Graeme , Silva, Rodrigo Santucci, Pylypenko, Halyna, Janssens, Ann , Pristupa, Alexander , Mayer, Jiří , Dilhuydy, Marie‐Sarah, Loscertales, Javier, Avigdor, Abraham, Rule, Simon , Sun, Steven , Mahler, Michelle, Salman, Mariya, Howes, Angela, Cramer, Paula , Demırkan, Fatih , Grosicki, Sebastian , Bartlett, Nancy L. , Hallek, Michael

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: LBA7005-LBA7005

10.1200/jco.2015.33.15_suppl.lba7005 Get It

Ruxolitinib safety experience in the polycythemia vera clinical trial program.
Martino, Bruno, He, Shui, Habr, Dany , Alecu, Iulian , Verstovšek, Srđan , Mesa, Ruben A. , Kiladjian, Jean‐Jacques , Jones, Mark M., Alecu, Iulian, Vannucchi, Alessandro M.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e18082-e18082

10.1200/jco.2015.33.15_suppl.e18082 Get It

Overall survival (OS) and baseline disease characteristics in MDS patients with primary HMA failure in a randomized, controlled, phase III study of rigosertib.
Fenaux, Pierre , Al‐Kali, Aref , Baer, Maria R. , Silverman, Lewis R. , Scott, Bart L. , Greenberg, Peter L. , Kreuzer, Karl Anton, Godley, Lucy A. , Collins, Robert H. , Azarnia, N., Garcia‐Manero, Guillermo , Godley, Lucy A , Sekeres, Mikkael A. , Roboz, Gail J. , Gaïdano, Gianluca , Platzbecker, Uwe , Steensma, David P. , Kreuzer, Karl‐Anton, Atallah, Ehab

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e18079-e18079

10.1200/jco.2015.33.15_suppl.e18079 Get It